ehp-101
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2019 (NCT04166552)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCC1=C(NCC2=CC=CC=C2)C(=O)C([C@@H]3C=C(C)CC[C@H]3C(C)=C)=C(O)C1=O- Mol. weight
- 433.5824 g/mol
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSKTJCIKNF3F ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04909502 | Phase 2 | Sep 30, 2021 | Emerald Health Pharmaceuticals |
| NCT04166552 | Phase 2 | Dec 31, 2019 | Emerald Health Pharmaceuticals, IQVIA |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Emerald Health Pharmaceuticals | For profit | 2 | 2 | 1 | 2019 |
| IQVIA | For profit | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1